Literature DB >> 19499089

Unexpected domain composition of MACC1 links MET signaling and apoptosis.

Katarzyna Kokoszyńska1, Jacek Kryński, Leszek Rychlewski, Lucjan S Wyrwicz.   

Abstract

Colorectal cancer, one of the most challenging malignancies, still has a limited number of recognized prognostic and predictive markers indicating appropriate treatment. MACC1 (metastasis-associated in colon cancer-1), a novel regulator of tumor growth and metastasis has recently been identified as an important prognostic factor of metastatic disease in colorectal cancer. The mechanism of MACC1 activity remains undetermined. Here we apply a combination of fold recognition and homology modeling algorithms to draft MACC1 function. The applied methods revealed that the MACC1 protein consists of four domains: ZU5, SH3, and two C-terminal death domains (DD). Previously a similar domain architecture (ZU5-DD) was observed in other proteins, involved mainly in signal transduction and apoptosis regulation. Based on the specific aspects of the closest homologues' biology functional hypotheses on MACC1 are proposed. A broad range of bioinformatic analyzes indicates that MACC1, besides its involvement in signal transduction from the MET receptor, links MET signaling and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19499089

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  26 in total

1.  Metastasis-associated colon cancer-1 is a novel prognostic marker for cervical cancer.

Authors:  Lan Guo; Wanggui Lu; Xuan Zhang; Dixian Luo; Hongwen Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  Positive MACC1 expression correlates with invasive behaviors and postoperative liver metastasis in colon cancer.

Authors:  Yunfei Ge; Xiangrui Meng; Yong Zhou; Jianliang Zhang; Yinlu Ding
Journal:  Int J Clin Exp Med       Date:  2015-01-15

3.  Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9.

Authors:  Jie Gao; Feihu Ding; Qingguang Liu; Yingmin Yao
Journal:  Mol Cell Biochem       Date:  2012-12-12       Impact factor: 3.396

4.  MACC1 overexpression predicts a poor prognosis for non-small cell lung cancer.

Authors:  Zhiqiang Wang; Zhi Li; Chen Wu; Yonggong Wang; Yang Xia; Liang Chen; Quan Zhu; Yijiang Chen
Journal:  Med Oncol       Date:  2013-12-06       Impact factor: 3.064

5.  In vivo imaging of colorectal cancer growth and metastasis by targeting MACC1 with shRNA in xenografted mice.

Authors:  Andreas Pichorner; Ulrike Sack; Dennis Kobelt; Inken Kelch; Franziska Arlt; Janice Smith; Wolfgang Walther; Peter M Schlag; Ulrike Stein
Journal:  Clin Exp Metastasis       Date:  2012-04-07       Impact factor: 5.150

Review 6.  MACC1 - more than metastasis? Facts and predictions about a novel gene.

Authors:  Ulrike Stein; Mathias Dahlmann; Wolfgang Walther
Journal:  J Mol Med (Berl)       Date:  2009-09-30       Impact factor: 4.599

7.  Over-expression of Metastasis-associated in Colon Cancer-1 (MACC1) Associates with Better Prognosis of Gastric Cancer Patients.

Authors:  Shao-Hua Ge; Xiao-Jiang Wu; Xiao-Hong Wang; Xiao-Fang Xing; Lian-Hai Zhang; Yu-Bing Zhu; Hong Du; Bin Dong; Ying Hu; Jia-Fu Ji
Journal:  Chin J Cancer Res       Date:  2011-06       Impact factor: 5.087

8.  Prognostic value and clinical pathology of MACC-1 and c-MET expression in gastric carcinoma.

Authors:  Jie Ma; Jun Ma; Qun Meng; Zhong-Sheng Zhao; Wen-juan Xu
Journal:  Pathol Oncol Res       Date:  2013-07-01       Impact factor: 3.201

9.  High expression of MACC1 predicts poor prognosis in patients with osteosarcoma.

Authors:  Kai Zhang; Yonggang Zhang; Huimin Zhu; Na Xue; Jie Liu; Chao Shan; Qing Zhu
Journal:  Tumour Biol       Date:  2013-09-25

10.  MACC1 is involved in the regulation of proliferation, colony formation, invasion ability, cell cycle distribution, apoptosis and tumorigenicity by altering Akt signaling pathway in human osteosarcoma.

Authors:  Kai Zhang; Fang Tian; Yonggang Zhang; Qing Zhu; Na Xue; Huimin Zhu; Heng Wang; Xinjun Guo
Journal:  Tumour Biol       Date:  2013-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.